Synopsys (SNPS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Werte in diesem Artikel
For the quarter ended April 2025, Synopsys (SNPS) reported revenue of $1.6 billion, up 10.3% over the same period last year. EPS came in at $3.67, compared to $3.00 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.6 billion, representing a surprise of +0.16%. The company delivered an EPS surprise of +8.26%, with the consensus EPS estimate being $3.39.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Synopsys performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Maintenance and service: $265.26 million versus $279.24 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -4.1% change. Revenue- Total products revenue: $1.34 billion compared to the $1.32 billion average estimate based on four analysts. The reported number represents a change of +13.7% year over year. Revenue by segment- Design IP: $482 million compared to the $443.37 million average estimate based on three analysts. The reported number represents a change of +20.6% year over year. Revenue by segment- Design Automation: $1.12 billion compared to the $1.16 billion average estimate based on three analysts. The reported number represents a change of +6.4% year over year. Revenue- Upfront products: $510.68 million versus the three-analyst average estimate of $415.15 million. The reported number represents a year-over-year change of +28.8%. Revenue- Time-based products: $828.33 million compared to the $904.12 million average estimate based on three analysts. The reported number represents a change of +6% year over year. View all Key Company Metrics for Synopsys here>>>Shares of Synopsys have returned +11.1% over the past month versus the Zacks S&P 500 composite's +7.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Synopsys, Inc. (SNPS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Q2
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Synopsys Inc.
Analysen zu Synopsys Inc.
Datum | Rating | Analyst | |
---|---|---|---|
22.08.2019 | Synopsys Buy | Needham & Company, LLC | |
03.04.2019 | Synopsys Buy | Needham & Company, LLC | |
28.03.2019 | Synopsys Buy | Needham & Company, LLC | |
06.12.2018 | Synopsys Buy | Needham & Company, LLC | |
06.12.2018 | Synopsys Buy | The Benchmark Company |
Datum | Rating | Analyst | |
---|---|---|---|
22.08.2019 | Synopsys Buy | Needham & Company, LLC | |
03.04.2019 | Synopsys Buy | Needham & Company, LLC | |
28.03.2019 | Synopsys Buy | Needham & Company, LLC | |
06.12.2018 | Synopsys Buy | Needham & Company, LLC | |
06.12.2018 | Synopsys Buy | The Benchmark Company |
Datum | Rating | Analyst | |
---|---|---|---|
09.09.2015 | Synopsys Hold | The Benchmark Company | |
04.12.2008 | Synopsys Upgrade | Citigroup Corp. | |
02.02.2007 | Synopsys neutral | DA Davidson | |
31.01.2007 | Update Synopsys Inc.: Neutral | DA Davidson | |
30.11.2006 | Synopsys hold | Deutsche Securities |
Datum | Rating | Analyst | |
---|---|---|---|
21.08.2008 | Synopsys Downgrade | Citigroup Corp. | |
24.06.2005 | Synopsys underweight | Prudential Financial |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synopsys Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen